Michael Patrick Ellis1, Daniella Lent-Schochet1,2, Therlinder Lo1,3, Glenn Yiu4. 1. Department of Ophthalmology and Vision Science, University of California Davis, 4860 Y Street Suite 2400, Sacramento, CA, 95817, USA. 2. California Northstate University College of Medicine, 9700 W Taron Drive, Elk Grove, CA, 95757, USA. 3. University of Nevada, Reno School of Medicine, 1664 North Virginia Street, Reno, NV, 89557-0357, USA. 4. Department of Ophthalmology and Vision Science, University of California Davis, 4860 Y Street Suite 2400, Sacramento, CA, 95817, USA. gyiu@ucdavis.edu.
Abstract
PURPOSE OF REVIEW: Diabetic retinopathy (DR) is the leading cause of vision loss in working-age adults in the developed world. This review discusses the current approach to managing the disease, such as glycemic and blood pressure control, as well as laser photocoagulation, as well as emerging concepts and controversies on novel therapies. RECENT FINDINGS: In recent years, the rise of intraocular anti-angiogenesis treatments is changing the paradigm of classic laser photocoagulation in the management of DR, but its long-term benefits remain an area of controversy. We also discuss new targets including anti-inflammation, neuroprotection, and novel laser technologies. Finally, we discuss new advances in retinal imaging that has vastly improved the diagnosis and management of DR. Diagnosis and management of diabetic retinopathy is a rapidly progressing field. Emerging concepts in ophthalmic imaging, medical treatments, and surgical approaches provide insights into how DR management will evolve in the near future.
PURPOSE OF REVIEW: Diabetic retinopathy (DR) is the leading cause of vision loss in working-age adults in the developed world. This review discusses the current approach to managing the disease, such as glycemic and blood pressure control, as well as laser photocoagulation, as well as emerging concepts and controversies on novel therapies. RECENT FINDINGS: In recent years, the rise of intraocular anti-angiogenesis treatments is changing the paradigm of classic laser photocoagulation in the management of DR, but its long-term benefits remain an area of controversy. We also discuss new targets including anti-inflammation, neuroprotection, and novel laser technologies. Finally, we discuss new advances in retinal imaging that has vastly improved the diagnosis and management of DR. Diagnosis and management of diabetic retinopathy is a rapidly progressing field. Emerging concepts in ophthalmic imaging, medical treatments, and surgical approaches provide insights into how DR management will evolve in the near future.
Entities:
Keywords:
Blood pressure; Diabetic retinopathy; Glycemic control
Authors: Wenying Fan; Kang Wang; Khalil Ghasemi Falavarjani; Min Sagong; Akihito Uji; Michael Ip; Charles C Wykoff; David M Brown; Jano van Hemert; SriniVas R Sadda Journal: Am J Ophthalmol Date: 2017-06-01 Impact factor: 5.258
Authors: Anne Katrin Sjølie; Ronald Klein; Massimo Porta; Trevor Orchard; John Fuller; Hans Henrik Parving; Rudy Bilous; Nish Chaturvedi Journal: Lancet Date: 2008-09-25 Impact factor: 79.321
Authors: Tien Y Wong; Jennifer Sun; Ryo Kawasaki; Paisan Ruamviboonsuk; Neeru Gupta; Van Charles Lansingh; Mauricio Maia; Wanjiku Mathenge; Sunil Moreker; Mahi M K Muqit; Serge Resnikoff; Juan Verdaguer; Peiquan Zhao; Frederick Ferris; Lloyd P Aiello; Hugh R Taylor Journal: Ophthalmology Date: 2018-05-24 Impact factor: 12.079
Authors: Lincoln T Shaw; Saira Khanna; Lindsay Y Chun; Rose C Dimitroyannis; Sarah H Rodriguez; Nathalie Massamba; Seenu M Hariprasad; Dimitra Skondra Journal: Cells Date: 2021-03-04 Impact factor: 6.600